-
Opinions of the General Office of the State Council on Comprehensively Deepening the Reform of Regulation of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry
2025-03-25
In order to thoroughly implement the important instructions and directives of General Secretary Xi Jinping on the regulation of drugs and medical devices and the development of the pharmaceutical industry, and to comprehensively deepen reforms in drug and medical device regulation to promote the high-quality development of the pharmaceutical industry, the following opinions are proposed with the approval of the State Council.
-
Ebronucimab Injection Approved for Marketing by China NMPA
2025-02-19
Recently, the Ebronucimab Injection (trade name: 伊喜宁) of Kangrong Dongfang (Guangdong) Pharmaceutical Co., Ltd. is approved for marketing by China NMPA.
-
Renatus® Transcatheter Aortic Valve System Approved for Marketing
2025-02-19
Recently, the innovative product "Renatus® Transcatheter Aortic Valve System" of Beijing Balance Medical Technology Co., Ltd. is approved by China NMPA.
-
JETSTREAM™ PVCN100 Console and JETSTREAM™ Over-The-Wire Atherectomy Catheter Approved for Marketing
2025-02-19
Recently, the two innovative products "JETSTREAM™ PVCN100 Console" and "JETSTREAM™ Over-The-Wire Atherectomy Catheter" of Boston Scientific Corporation are approved by China NMPA.
-
Lumipulse® G HBsAg-Quant Approved for Marketing
2025-02-19
Recently, the innovative product "Lumipulse® G HBsAg-Quant" of Fujirebio Inc. is approved by China NMPA.
-
Navigational Positioning Microwave Ablation System Approved for Marketing
2025-02-19
Recently, the innovative product "Navigational Positioning Microwave Ablation System" of True Health (Beijing) Medical Technology Co., Ltd. is approved by China NMPA.
